<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Vassiliadis, I</style></author><author><style face="normal" font="default" size="100%">Thomopoulou, S</style></author><author><style face="normal" font="default" size="100%">Mavrogeni, S</style></author><author><style face="normal" font="default" size="100%">Papadopoulou, E.</style></author><author><style face="normal" font="default" size="100%">Giamouzis, G</style></author><author><style face="normal" font="default" size="100%">Cokkinos, D.V.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">553 Reduction of circulating levels of brain natriuretic peptide and C-reactive protein in patients with congestive heart failure after intermittent administration of levosimendan for 3 months</style></title><secondary-title><style face="normal" font="default" size="100%">European Journal of Heart Failure Supplements</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2006</style></year></dates><volume><style face="normal" font="default" size="100%">5</style></volume><pages><style face="normal" font="default" size="100%">123–123</style></pages><language><style face="normal" font="default" size="100%">eng</style></language></record></records></xml>